Cranberry/Chondroitin Sulfate Co-precipitate as a New Method for Controlling Urinary Tract Infections.
Concetta CagliotiRossana IannittiGiada CeccarelliLaura SelanMarco ArtiniRosanna PapaAntonio MalvasiRosaria GentileDiletta Del BiancoFlorinda AponePaola AngeliniFederico PalazzettiBernard FiorettiPublished in: Antibiotics (Basel, Switzerland) (2023)
Urinary tract infections (UTI), which are among the most frequent cases of infectious diseases, mainly affect women. The most common treatment approach involves the use of antibiotics, although this solution is not always the most suitable, mainly because of the resistance that bacterial strains develop. Proanthocyanidins are a class of polyphenols, abundantly contained in cranberry extracts, which have shown beneficial effects in the treatment of urinary tract infections, due to their anti-adhesive properties toward bacteria, with respect to the membranes of the cells of the urothelium and intestine, thus reducing their virulence. In this work, we demonstrate via microscopy and scattering measurements how a mixture of cranberry and chondroitin sulfate can form a crosslinked structure with barrier properties. By using a design of experiment (DOE), we optimized the mass ratio to obtain a precipitate between cranberry extract and chondroitin sulfate in the presence of N-acetylcysteine and hyaluronic acid. By using transepithelial electrical resistance (TEER) chambers, we confirmed the barrier properties of the best mixture obtained with the DOE. Lastly, the antibiofilm action was investigated against five strains of Escherichia coli with different antibiotic sensitivity. The precipitate displayed a variable inhibitory effect in biofilm formation with major effects in UTI with an antibiotic resistance profile.
Keyphrases
- urinary tract infection
- hyaluronic acid
- escherichia coli
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- infectious diseases
- induced apoptosis
- candida albicans
- high resolution
- oxidative stress
- polycystic ovary syndrome
- antimicrobial resistance
- cystic fibrosis
- single molecule
- cell proliferation
- high speed
- multidrug resistant
- anti inflammatory
- insulin resistance